From: Predicting risk of malignancy in subgroups of B3 breast lesions
Pathology | Number | Odds ratio | Pvalue | 95% CI |
---|---|---|---|---|
Atypia | 53 | 7.48 | < 0.001* | 2.62 to 21.39 |
AIDP | 10 | 4.87 | 0.034* | 1.13 to 21.01 |
ADH | 11 | 2.50 | 0.167 | 0.68 to 9.24 |
ALH | 6 | 1.28 | 0.793 | 0.21 to 7.93 |
FEA | 8 | 5.90 | 0.025* | 1.25 to 27.67 |
CCC | 31 | 5.10 | 0.001* | 1.89 to 13.76 |
Papillary | 14 | 0.57 | 0.44 | 0.14 to 2.38 |
LISN | 30 | 0.55 | 0.28 | 0.18 to 1.64 |
RS/CSL | 13 | 0.92 | 0.91 | 0.23 to 3.74 |
Epithelial proliferation | 20 | 2.07 | 0.172 | 0.73 to 5.88 |
Mucocele-like | 6 | 1.91 | 0.48 | 0.32 to 11.41 |
Fibroepithelial | 10 | No malignant diagnoses | ||
Haemangioma | 1 | No malignant diagnoses | ||
Spindle cell | 2 | No malignant diagnoses |